bioMerieux S.A. (BIM) - Product Pipeline Analysis, 2017 Update

Date: June 29, 2017
Pages: 63
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: B57860BA643EN
Leaflet:

Download PDF Leaflet

bioMerieux S.A. (BIM) - Product Pipeline Analysis, 2017 Update
Summary

bioMerieux S.A. (bioMerieux) designs, develops and manufactures diagnostic systems and reagents for physicians and biologists. The company offers diagnostic solutions such as instruments, reagents and software. bioMerieux products are used diagnosing and managing infectious diseases, cardiovascular diseases and targeted cancers. The company also provides solutions for the enumeration of microbial flora, detection of specific pathogenic bacteria, monitoring of air and surface quality and sterility testing for agri-food, cosmetics and pharmaceutical industries. The company conducts its operations through subsidiaries and a broad network of distributors. bioMerieux is a part of the Institut Merieux group and is headquartered in Marcy l’Etoile, France.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company bioMerieux S.A.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
bioMerieux S.A. Company Overview
bioMerieux S.A. Company Snapshot
bioMerieux S.A. Pipeline Products and Ongoing Clinical Trials Overview
bioMerieux S.A. – Pipeline Analysis Overview
Business Description
bioMerieux S.A. - Key Facts
bioMerieux S.A. - Major Products and Services
bioMerieux S.A. Pipeline Products by Development Stage
bioMerieux S.A. Ongoing Clinical Trials by Trial Status
bioMerieux S.A. Pipeline Products Overview
Annexin A3 Prostate Cancer Marker
Annexin A3 Prostate Cancer Marker Product Overview
BRAF - Breast Cancer Diagnostic Kit
BRAF - Breast Cancer Diagnostic Kit Product Overview
CancerTARGET ID
CancerTARGET ID Product Overview
CancerTREATMENT ID
CancerTREATMENT ID Product Overview
CancerTYPE ID
CancerTYPE ID Product Overview
Companion Diagnostic Test - Hormone-Dependent Breast Cancer
Companion Diagnostic Test - Hormone-Dependent Breast Cancer Product Overview
Companion Diagnostic Test - Hormone-Dependent Neuro Endocrine Tumor
Companion Diagnostic Test - Hormone-Dependent Neuro Endocrine Tumor Product Overview
Companion Diagnostic Test - Hormone-Dependent Pituitary Tumor
Companion Diagnostic Test - Hormone-Dependent Pituitary Tumor Product Overview
Companion Diagnostic Test - Hormone-Dependent Prostate Cancer
Companion Diagnostic Test - Hormone-Dependent Prostate Cancer Product Overview
Diagnostic Assay - Prostate Cancer
Diagnostic Assay - Prostate Cancer Product Overview
Diagnostic Test - Colorectal Cancer
Diagnostic Test - Colorectal Cancer Product Overview
Diagnostic Test - Tuberculosis
Diagnostic Test - Tuberculosis Product Overview
FilmArray Biothreat-E Test
FilmArray Biothreat-E Test Product Overview
FilmArray Direct Sepsis Panel
FilmArray Direct Sepsis Panel Product Overview
FilmArray Febrile Infant Panel
FilmArray Febrile Infant Panel Product Overview
FilmArray Febrile Infant Panel Clinical Trial
FilmArray NGDS BT-E Assay
FilmArray NGDS BT-E Assay Product Overview
FilmArray Pneumonia Pathogen Panel
FilmArray Pneumonia Pathogen Panel Product Overview
FilmArray STD Panel
FilmArray STD Panel Product Overview
iMAG
iMAG Product Overview
Magnotech System
Magnotech System Product Overview
Magnotech System - Cardiovascular Disease Assay
Magnotech System - Cardiovascular Disease Assay Product Overview
NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test
NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test Product Overview
NucliSENS EasyQ Legionella spp Molecular Test
NucliSENS EasyQ Legionella spp Molecular Test Product Overview
NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test
NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test Product Overview
VIDAS CRP Assay
VIDAS CRP Assay Product Overview
bioMerieux S.A. - Key Competitors
bioMerieux S.A. - Key Employees
bioMerieux S.A. - Key Employee Biographies
bioMerieux S.A. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
bioMerieux S.A., Recent Developments
Jun 08, 2017: New Data From Biotheranostics Further Demonstrate the Value of CancerTYPE ID to Help Identify Metastatic Cancers with an Unknown or Unclear Tumor Type Diagnosis
Jun 05, 2017: New Data Affirms Value of Breast Cancer Index (BCI) in Identification of Early Stage ER+ Breast Cancer Patients Appropriate for Extended Endocrine Therapy
Jun 01, 2017: bioMérieux receives FDA Clearance for BioFire’s FilmArray Respiratory Panel 2 (RP2)
May 18, 2017: Biotheranostics Appoints Don Hardison as New Chief Executive Officer
May 02, 2017: Biotheranostics Presents First Data from the BCI Clinical Database for Correlative Studies
Apr 20, 2017: bioMerieux – First-Quarter 2017 Business Review
Apr 05, 2017: bioMerieux receives FDA 510(k) clearance for its BacT/ALERT VIRTUO fully automated blood culture system
Mar 15, 2017: Breast Cancer Index (BCI) Included in Updated Guidelines for Use of Clinical Biomarkers in Breast Cancer
Mar 10, 2017: Study Demonstrates Use of Breast Cancer Index Leads to Significant Changes in Physician Recommendations for Extended Endocrine Therapy in ER+ Breast Cancer Patients
Feb 24, 2017: bioMerieux’s VIDAS B.R.A.H.M.S PCT becomes the first FDA-cleared procalcitonin assay as an aid for antibiotic stewardship in respiratory infections and sepsis
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

bioMerieux S.A. Pipeline Products and Ongoing Clinical Trials Overview
bioMerieux S.A. Pipeline Products by Equipment Type
bioMerieux S.A. Pipeline Products by Indication
bioMerieux S.A. Ongoing Clinical Trials by Trial Status
bioMerieux S.A., Key Facts
bioMerieux S.A., Major Products and Services
bioMerieux S.A. Number of Pipeline Products by Development Stage
bioMerieux S.A. Pipeline Products Summary by Development Stage
bioMerieux S.A. Ongoing Clinical Trials by Trial Status
bioMerieux S.A. Ongoing Clinical Trials Summary
Annexin A3 Prostate Cancer Marker - Product Status
Annexin A3 Prostate Cancer Marker - Product Description
BRAF - Breast Cancer Diagnostic Kit - Product Status
BRAF - Breast Cancer Diagnostic Kit - Product Description
CancerTARGET ID - Product Status
CancerTARGET ID - Product Description
CancerTREATMENT ID - Product Status
CancerTREATMENT ID - Product Description
CancerTYPE ID - Product Status
CancerTYPE ID - Product Description
Companion Diagnostic Test - Hormone-Dependent Breast Cancer - Product Status
Companion Diagnostic Test - Hormone-Dependent Breast Cancer - Product Description
Companion Diagnostic Test - Hormone-Dependent Neuro Endocrine Tumor - Product Status
Companion Diagnostic Test - Hormone-Dependent Neuro Endocrine Tumor - Product Description
Companion Diagnostic Test - Hormone-Dependent Pituitary Tumor - Product Status
Companion Diagnostic Test - Hormone-Dependent Pituitary Tumor - Product Description
Companion Diagnostic Test - Hormone-Dependent Prostate Cancer - Product Status
Companion Diagnostic Test - Hormone-Dependent Prostate Cancer - Product Description
Diagnostic Assay - Prostate Cancer - Product Status
Diagnostic Assay - Prostate Cancer - Product Description
Diagnostic Test - Colorectal Cancer - Product Status
Diagnostic Test - Colorectal Cancer - Product Description
Diagnostic Test - Tuberculosis - Product Status
Diagnostic Test - Tuberculosis - Product Description
FilmArray Biothreat-E Test - Product Status
FilmArray Biothreat-E Test - Product Description
FilmArray Direct Sepsis Panel - Product Status
FilmArray Direct Sepsis Panel - Product Description
FilmArray Febrile Infant Panel - Product Status
FilmArray Febrile Infant Panel - Product Description
FilmArray Febrile Infant Panel - Pilot Evaluation of the FilmArray Febrile Infant (FI) Panel
FilmArray NGDS BT-E Assay - Product Status
FilmArray NGDS BT-E Assay - Product Description
FilmArray Pneumonia Pathogen Panel - Product Status
FilmArray Pneumonia Pathogen Panel - Product Description
FilmArray STD Panel - Product Status
FilmArray STD Panel - Product Description
iMAG - Product Status
iMAG - Product Description
Magnotech System - Product Status
Magnotech System - Product Description
Magnotech System - Cardiovascular Disease Assay - Product Status
Magnotech System - Cardiovascular Disease Assay - Product Description
NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test - Product Status
NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test - Product Description
NucliSENS EasyQ Legionella spp Molecular Test - Product Status
NucliSENS EasyQ Legionella spp Molecular Test - Product Description
NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test - Product Status
NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test - Product Description
VIDAS CRP Assay - Product Status
VIDAS CRP Assay - Product Description
bioMerieux S.A., Key Employees
bioMerieux S.A., Key Employee Biographies
bioMerieux S.A., Other Locations
bioMerieux S.A., Subsidiaries
Glossary

LIST OF FIGURES

bioMerieux S.A. Pipeline Products by Equipment Type
bioMerieux S.A. Pipeline Products by Development Stage
bioMerieux S.A. Ongoing Clinical Trials by Trial Status

COMPANIES MENTIONED

Siemens Healthcare GmbH
Ortho-Clinical Diagnostics Inc
F. Hoffmann-La Roche Ltd
Cepheid
Becton Dickinson and Co
Beckman Coulter Inc
Skip to top


Ask Your Question

bioMerieux S.A. (BIM) - Product Pipeline Analysis, 2017 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: